Abstract
A double blind study was undertaken to compare the efficacy between centbutindole and haloperidol. A total of 44 patients suffering from schizophrenia diagnosed in accordance to ICD-10 criteria were included. They were randomly assigned into two groups receiving centbutindole (4.5 mg) or haloperidol (15 mg) in two divided doses per day for six weeks. Each patient was evaluated on Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression Scale (CGI-S) and UKU side effect scale every week. Five patients (1 patient in centbutindole group, 4 patients in haloperidol group) dropped out due to various reasons. A total of 39 patients (21 patients in centbutindole group and 18 patients in haloperidol group) completed the study. The results revealed an early onset of therapeutic effect with centbutindole for both positive and negative symptoms. However, the efficacy was comparable between centibutindole and haloperidol from 3rd week onwards.
Keywords: Centbutindole, schizophrenia, antipsychotic, haloperidol
Full Text
The Full Text of this article is available as a PDF (191.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Doongaji D. R., Sheth A. S., Paul T., Parikh R. M., Vahora S. A., Apte J. S., Desai N. K., Upadhaya A. K., Satoskar R. S. Clinical evaluation of centbutindole as an anti-psychotic agent. Indian J Med Res. 1983 Jul;78:126–133. [PubMed] [Google Scholar]
- Gulati A., Bhargava H. N. Effect of melanotropin release inhibiting factor on changes by haloperidol and centbutindole in cerebral cortical 5-hydroxytryptamine receptors. Pharmacology. 1990;41(2):98–106. doi: 10.1159/000138704. [DOI] [PubMed] [Google Scholar]
- Gulati A., Srimal R. C., Dhawan B. N. Differential alteration in striatal dopaminergic and cortical serotonergic receptors induced by repeated administration of haloperidol or centbutindole in rats. Pharmacology. 1988;36(6):396–404. doi: 10.1159/000138328. [DOI] [PubMed] [Google Scholar]
- Kay S. R., Opler L. A., Lindenmayer J. P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res. 1988 Jan;23(1):99–110. doi: 10.1016/0165-1781(88)90038-8. [DOI] [PubMed] [Google Scholar]
- Saxena A. K., Jain P. C., Anand N. Agents acting on the central nervous system. 15. 2-Substituted 1,2,3,4,6,7,12,12a-octahydropyrazino(2',1':6,1)pyrido(3,4-b)indoles. A new class of central nervous system depressants. J Med Chem. 1973 May;16(5):560–564. doi: 10.1021/jm00263a036. [DOI] [PubMed] [Google Scholar]